Relative Strength Chart Sarepta Therapeutics, Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 01:49:00 07/02/2026 am IST			5-day change	1st Jan Change
18.48 ^USD	+8.49%		-9.34%	-14.31%

04/02	Sarepta Therapeutics announces clinical trial application approval for SRP-1005 in Huntington's disease	RE
04/02	Sarepta Therapeutics Announces Approval of Clinical Trial Application for SRP-1005, Its Investigational Treatment for Huntington's Disease	CI

End-of-day quotes

		Sector	Change	5d. change	Varia. Jan 1.	1-year change	5-years change	Capi.	ST	MT	LT
	SAREPTA THERAPEUTICS, INC.	Diagnostic & Testing Substances Manufacturers	+8.25%	-9.34%	-14.31%	-83.55%	-80.65%	178.45Cr